MedPath

IRRIMAX Corporation

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
4 (100.0%)

Retrospective Independent Safety Review of Closed Irrisept Study

Not Applicable
Completed
Conditions
Adverse Events
First Posted Date
2022-05-04
Last Posted Date
2023-08-14
Lead Sponsor
Irrimax Corporation
Target Recruit Count
592
Registration Number
NCT05359666
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Arizona Department of Surgery, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles County & USC Medical Center, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Denver Health Medical Center, Denver, Colorado, United States

and more 14 locations

The Effect of Wound Irrigation With Irrisept on Abscess Healing (Irrisept UF Study)

Not Applicable
Terminated
Conditions
Abscess
First Posted Date
2021-07-12
Last Posted Date
2022-02-02
Lead Sponsor
Irrimax Corporation
Target Recruit Count
35
Registration Number
NCT04957732
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Florida, Shands Emergency Department, Gainesville, Florida, United States

Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections

Not Applicable
Terminated
Conditions
Surgical Site Infection
First Posted Date
2014-10-02
Last Posted Date
2022-05-24
Lead Sponsor
Irrimax Corporation
Target Recruit Count
627
Registration Number
NCT02255487
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Arizona, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

The University of Southern California, USC Medical Center, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Denver Health and Hospital Authority, Denver, Colorado, United States

and more 14 locations

The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

Not Applicable
Terminated
Conditions
Abscess
Skin and Soft Tissue Infections
First Posted Date
2010-02-25
Last Posted Date
2021-08-23
Lead Sponsor
Irrimax Corporation
Target Recruit Count
114
Registration Number
NCT01076049
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Tampa General Hospital - University of South Florida, Tampa, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.